September 2024 – Page 4

Scientists do not know why childhood BMI seems to be linked with schizophrenia but suggest that excess weight might alter the structure of young brains.

Sep 14 2024

Uncategorized

Neurocrine Biosciences Provides Update on ERUDITE™ Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia

by Clinical Editor

No Comments

Second Phase 2 Study for Luvadaxistat Fails to Meet Primary Endpoint as Potential Treatment for Cognitive Impairment Associated with SchizophreniaResults Confounded by Variability in Cognition Measures Across Population Studied and...

Sep 13 2024

Uncategorized

How to tell the differences between bipolar vs schizophrenia

by Clinical Editor

No Comments

It’s crucial to understand bipolar vs schizophrenia, especially the differences. Mental health issues are complex in nature. It’s possible that a person receives a dual diagnosis. Often, they may have...

Sep 13 2024

Uncategorized

New treatments being developed for schizophrenia

by Clinical Editor

No Comments

Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.

Sep 12 2024

Uncategorized

Schizophrenia & Psychosis Guide: Care, Advocacy, Engagement – NAMI: National Alliance on Mental Illness

by Clinical Editor

No Comments

Schizophrenia & Psychosis Guide: Care, Advocacy, Engagement NAMI: National Alliance on Mental Illness

Sep 12 2024

Uncategorized

New insights into the genetics of schizophrenia

by Clinical Editor

No Comments

In the complex landscape of mental health research, a new peer-reviewed viewpoint offers a critical examination of how genes and environment conspire to influence schizophrenia risk. Published in …

Sep 11 2024

Uncategorized

Unraveling schizophrenia: New insights into genetic and environmental interplay

by Clinical Editor

No Comments

In the complex landscape of mental health research, a new viewpoint offers a critical examination of how genes and environment conspire to influence schizophrenia risk. Published in Genomic Psychiatry …

Sep 11 2024

Uncategorized

Antipsychotic Use in Schizophrenia and Infection Risks During COVID-19

by Clinical Editor

No Comments

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry study,” published in …

Month: September 2024